Secretor polymorphism and human immunodeficiency virus infection in Senegalese women

Journal of Infectious Diseases

Volumn 181, Issue 2, 2000, Pages 737-739

  Ali, Suleman ^a   Niang, Mame Awa Faye ^b   N'doye, Ibraham ^c   Critchlow, Cathy W ^d   Hawes, Stephen E ^d   Hill, Adrian V S ^a   Kiviat, Nancy B ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c Institut dHygiene Sociale Dakar   (Senegal)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; FUCOSYLTRANSFERASE;

ARTICLE; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENEGAL; VIRUS RESISTANCE;

ADULT; FEMALE; FUCOSYLTRANSFERASES; GENETIC PREDISPOSITION TO DISEASE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNITY, MUCOSAL; POLYMORPHISM, GENETIC; PROSTITUTION; SENEGAL;

EID: 0034008699     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315234     Document Type: Article

References (15)

1. Henry S, Oriol R, Samuelsson B. Lewis histo-blood group system and associated secretory phenotypes. Vox Sang 1995; 69:166-82.
2. Navas EL, Venegas MF, Duncan JL, Anderson BE, Chmiel JS, Schaeffer AJ. Blood group antigen expression on vaginal and buccal epithelial cells and mucus in secretor and nonsecretor women. J Urol 1993; 149:1492-8.
3. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. Sequence and expression of a candidate for the human secretor blood group alpha(1,2)fucosyltransferase gene (FUT2): homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 1995; 270:4640-9.
4. Kinane DF, Blackwell CC, Brettle RP, Weir DM, Winstanley FP, Elton RA. ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br Med J (Clin Res Ed) 1982; 285:7-9.
5. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, Rogatko A, Fair WR. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 1989; 320:773-7.
6. Stapleton A, Nudelman E, Clausen H, Hakomori S, Stamm WE. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest 1992; 90:965-72.
7. Blackwell CC, Jonsdottir K, Hanson M, et al. Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet 1986; 2:284-5.
8. Raza MW, Blackwell CC, Molyneaux P, et al. Association between secretor status and respiratory viral illness. BMJ 1991; 303:815-8.
9. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infections in female university students as determined by a PCR-based method. JAMA 1991; 265:472-7.
10. Blackwell CC, James VS, Davidson S, et al. Secretor status and heterosexual transmission of HIV. BMJ 1991; 303:825-6.
11. Harouse JM, Bhat S, Spitalnik SL, et al. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 1991; 253:320-3.
12. Yahi N, Baghdiguian S, Moreau H, Fantini J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J Virol 1992; 66:4848-54.
13. Furuta Y, Eriksson K, Svennerholm B, et al. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci USA 1994; 91:12559-63.
14. Bjork S, Breimer ME, Hansson GC, Karlsson KA, Leffler H. Structures of blood group glycosphingolipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotype of the donor. J Biol Chem 1987; 262:6758-65.
15. Zopf D, Roth S. Oligosaccharide anti-infective agents. Lancet 1996; 347:1017-21.